Clinical Scorecard: Achieving Textbook Outcomes After Robotic Pancreatic Enucleation: A Two-Center Assessment of an Optimal Perioperative Pathway

At a Glance

Key Highlights

• The study proposed an rPE-specific textbook outcome (rPE-TO) tailored to the procedure’s therapeutic objectives.
• Achieving rPE-TO required meeting all six criteria: no conversion to open surgery, complete resection without reoperation, no clinically relevant postoperative pancreatic fistula, no major complication, no 30-day readmission, and survival through 90 days.
• Major complications were defined as Clavien–Dindo grade IIIa or higher; clinically relevant pancreatic fistula was ISGPS grade B or C.
• The proposed outcome was assessed in two independent institutional cohorts, with a combined multivariable analysis adjusted for center.
• The supplied article excerpt does not report outcome rates or factors associated with rPE-TO failure.

Guideline-Based Recommendations

Diagnosis

• Preoperative lesion evaluation included CT or MRI; pancreatic-head lesions also received contrast-enhanced CT to assess relationships with neighboring vessels.
• Preoperative laboratory testing included CA 19-9 and CEA.
• An interdisciplinary tumor board reviewed patients with neuroendocrine tumors. Radiological findings determined whether additional PET imaging or endoscopic biopsy was performed.

Management

• The study describes rPE as a parenchyma-sparing procedure for benign and low-grade malignant lesions.

Monitoring & Follow-up

• The rPE-TO included clinically relevant postoperative pancreatic fistula, major complications, readmission within 30 days, and survival through 90 days.

Risks

• Failure to meet any of the six rPE-TO components precluded achievement of the composite: no conversion to open surgery, complete resection without reoperation, no clinically relevant POPF, no major complication, no 30-day readmission, and survival through 90 days.

Patient & Prescribing Data

Adults aged 18 years or older undergoing completed rPE for benign or low-grade malignant pancreatic lesions at either study center.

The study evaluates a surgical procedure and perioperative pathway; it provides no medication or prescribing data in the supplied excerpt.

Clinical Best Practices

• The study defined major complications as Clavien–Dindo grade IIIa or higher and clinically relevant POPF as ISGPS grade B or C.
• The study was a retrospective, two-center cohort; the supplied excerpt does not report outcome rates or factors associated with rPE-TO failure.

Related Resources & Content